The European regulator’s anniversary year featured first-in-class therapies, rare-disease advances, safety warnings, and new ...
EMA cracks down on JAK inflammatory disease drugs, limiting AbbVie's Rinvoq and more on safety risks
More than one year after the FDA’s dreaded boxed warning addition and treatment line demotion, the JAK inhibitor class of inflammatory disease drugs has gotten its uses restricted on the other side of ...
The reform grants eight years of regulatory data and market protection, with extensions for drugs addressing unmet needs. EMA's procedures will be streamlined, reducing assessment times and ...
Investing.com -- Theriva Biologics Inc (NYSE American:TOVX) stock surged 25.4% in Monday premarket trading after the company announced receiving positive scientific advice from the European Medicines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback